Full Text View
Tabular View
No Study Results Posted
Related Studies
Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Medical College of Wisconsin.
Recruitment status was  Active, not recruiting
Study NCT01196117   Information provided by Medical College of Wisconsin

First Received on September 3, 2010.   Last Updated on September 29, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sleep Apnea
Sleep Disordered Breathing
Additional conditions recognized in this trial
Apnea
Respiratory Aspiration
Sleep Apnea Syndromes
More general conditions related to this trial
Dyssomnias
Nervous System Diseases
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms
Signs and Symptoms, Respiratory
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
14 days of CPAP therapy
14 days of placebo therapy
Additional drug interventions recognized in this trial
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone-17-butyrate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Dermatologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Medical College of Wisconsin
ResMed


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services